PureTech Health Plc (PRTC) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

PureTech Health Plc

Optibiotix Health Plc

Scancell Holdings Plc

Diaceutics Plc

Ondine Biomedical, Inc.

4basebio Plc

Oxford Biomedica Plc

e-Therapeutics Plc

HemoGenyx Pharmaceuticals Plc

Oxford BioDynamics Plc

Oncimmune Holdings Plc

Why is PureTech Health Plc ?

Poor Management Efficiency with a low ROE of 1.71%

The company has been able to generate a Return on Equity (avg) of 1.71% signifying low profitability per unit of shareholders funds

Poor long term growth as Operating profit has grown by an annual rate 0.56% of over the last 5 years

The company declared positive results in Dec'24 after negative results in Jun'24

OPERATING CASH FLOW(Y) Highest at GBP -188.62 MM
ROCE(HY) Highest at 11.74%
DEBT-EQUITY RATIO (HY) Lowest at -83.53 %

With ROE of 11.47%, it has a very attractive valuation with a 1.22 Price to Book Value

Over the past year, while the stock has generated a return of -26.65%, its profits have risen by 124.4% ; the PEG ratio of the company is 0.1

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -26.65% returns in the last 1 year, the stock has also underperformed FTSE 100 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to PureTech Health Plc should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is PureTech Health Plc for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

PureTech Health Plc

-100.0%

-1.00

45.65%

FTSE 100

16.5%

1.23

12.99%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-12.70%

EBIT Growth (5y)

0.56%

EBIT to Interest (avg)

-17.27

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.87

Sales to Capital Employed (avg)

0.02

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.02%

ROCE (avg)

ROE (avg)

1.71%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.22

EV to EBIT

-1.16

EV to EBITDA

-1.19

EV to Capital Employed

2.30

EV to Sales

21.27

PEG Ratio

0.08

Dividend Yield

ROCE (Latest)

-199.17%

ROE (Latest)

11.47%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is working for PureTech Health Plc

Pre-Tax Profit

At GBP 74.92 MM has Grown at 202.31%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (GBP MM)

Net Profit

At GBP 83.26 MM has Grown at 194.14%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (GBP MM)

Debt-Equity Ratio

Lowest at -83.53 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Operating Cash Flow

Highest at GBP -188.62 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (GBP MM)

Pre-Tax Profit

Highest at GBP 74.92 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (GBP MM)

Net Profit

Highest at GBP 83.26 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (GBP MM)

EPS

Highest at GBP 0.28

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (GBP)

Raw Material Cost

Fallen by -6,130% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales